Science
Mechanism of Action
This heptapeptide functions by signaling cellular pathways to activate the skin's endogenous repair systems. It is understood to stimulate the synthesis of key structural proteins such as integrins and keratins, crucial for robust skin barrier function and cell-to-cell adhesion, thereby contributing to increased skin firmness. Furthermore, it may enhance the biosynthesis and secretion of laminin-5 and B1 integrins, which are vital for maintaining the structural integrity and proper function of the basement membrane. Research indicates that heptapeptides can upregulate the production of collagen-producing genes (Collagen I and Collagen III), essential for connective tissue support, and stimulate fibronectin biosynthesis, which is integral to wound healing, cellular adhesion, growth, migration, and differentiation. Collectively, these actions promote cell proliferation, improve skin elasticity, enhance overall collagen synthesis, and refine skin texture.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Stability
Specific optimal pH for HEPTAPEPTIDE-20 stability is not documented; however, peptides generally exhibit varying stability profiles, with some showing optimal stability around pH 4.5. To enhance stability and improve dermal penetration, peptides are frequently integrated into encapsulated delivery systems, such as Solid Lipid Nanoparticles (SLN), which protect labile actives and facilitate controlled release.
Conflicts
- Aqueous solutions containing polysorbates, common emulsifiers, are susceptible to autoxidation when exposed to light, elevated temperatures, and copper sulfate, potentially compromising peptide stability. Autoclaving polysorbates, particularly with metal cations in buffer solutions, is not advised due to potential degradation and property changes.
- As with many peptide-based compounds, there is a theoretical concern regarding immunogenicity, which could lead to unwanted immune responses.
Safety
Safety Profile
A specific safety assessment for HEPTAPEPTIDE-20 by the CIR or SCCS is currently unavailable. It is important to note that Semax, a different heptapeptide classified as a '503A Category 2 Bulk Drug Substance,' carries significant safety concerns and restrictions for general human use in a drug context, but this information pertains to a distinct peptide and pharmaceutical application, not the cosmetic use of HEPTAPEPTIDE-20.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While the general mechanism of heptapeptides suggests promising benefits for skin structure and renewal, the absence of specific clinical efficacy data, detailed safety assessments, and optimal formulation parameters for HEPTAPEPTIDE-20 leads to an 'insufficient-data' verdict for precise application guidance.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources